A VH4-34+ myeloma protein with weak autoreactivity

Haematologica

Volumn 92, Issue 5, 2007, Pages 690-693

  Frøyland, Marianne ^a   Thompson, Keith M ^a,d   Thorpe, Susan J ^b   Sahota, Surinder S ^c   Gedde Dahl, Tobias ^d   Bogen, Bjarne ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autoreactivity; Myeloma protein; VH4 34

Indexed keywords

IMMUNOGLOBULIN A; PARAPROTEIN; ANTINUCLEAR ANTIBODY; HYBRID PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BONE MARROW; CANCER STAGING; GENE SEQUENCE; HUMAN; MASS SPECTROMETRY; MOLECULAR CLONING; MONONUCLEAR CELL; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; AGED; AMINO ACID SEQUENCE; ANTIGEN ANTIBODY REACTION; AUTOIMMUNITY; B LYMPHOCYTE; CANCER STEM CELL; CELL CLONE; GENE DELETION; GENE REARRANGEMENT; GENETICS; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOLECULAR GENETICS; PATHOLOGY; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AGED; AMINO ACID SEQUENCE; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; AUTOIMMUNITY; B-LYMPHOCYTES; BASE SEQUENCE; CLONE CELLS; DNA MUTATIONAL ANALYSIS; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; MYELOMA PROTEINS; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; SELF TOLERANCE; SEQUENCE ALIGNMENT; SEQUENCE DELETION; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR STEM CELLS;

EID: 34447311727     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10850     Document Type: Article

References (20)

1. Pugh-Bernard AE, Silverman GJ, Cappione AJ, Villano ME, Ryan DH, Insel RA et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 2001;108:1061-70.
2. Pascual V, Victor K, Spellerberg M, Hamblin TJ, Stevenson FK, Capra JD. VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol 1992; 149:2337-44.
3. Isenberg DA, McClure C, Farewell V, Spellerberg M, Williams W, Cambridge G, et al. Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 1998; 57: 566-70.
4. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515-25.
5. Hsu FJ, Levy R. Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. Blood 1995; 86: 3072-82.
6. Kosmas C, Stamatopoulos K, Stavroyianni N, Zoi K, Belessi C, Viniou N, et al. Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoire. Leukemia 2000; 14:1718-26.
7. Rettig MB, Vescio RA, Cao J, Wu CH, Lee JC, Han E et al. VH gene usage in multiple myeloma: complete absence of the VH4.21 (VH4-34) gene. Blood 1996;87:2846-52.
8. Gonzalez D, Gonzalez M, Balanzategui A, Sarasquete ME, Lopez-Perez R, Chillon MC, et al. Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma. Haematologica 2005;90:906-13.
9. Hadzidimitriou A, Stamatopoulos K, Belessi C, Lalayianni C, Stavroyianni N, Smilevska T et al. Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases. Haematologica 2006;91:781-7.
10. Sahota SS, Townsend M, Stevenson FK. Identification and assembly of V genes as idiotype-specific DNA fusion vaccines in multiple myeloma. Methods MoI Med 2005; 113: 105-19.
11. Stevenson FK, Wrightham M, Glennie MJ, Jones DB, Cattan AR, Feizi T, et al. Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. Blood 1986;68:430-6.
12. Johansen FE, Braathen R, Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J Immunol 2001; 167:5185-92.
13. Holm A, Rise F, Sessler N, Sollid LM, Undheim K, Fleckenstein B. Specific modification of peptide-bound citrulline residues. Anal Biochem 2006; 352:68-76.
14. Potter KN, Hobby P, Klijn S, Stevenson FK, Sutton BJ. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol 2002;169:3777-82.
15. Thorpe SJ, Boult CE, Stevenson FK, Scott ML, Sutherland J, Spellerberg MB et al. Cold agglutinin activity is common among human monoclonal IgM Rh system antibodies using the V4-34 heavy chain variable gene segment. Transfusion 1997;37:1111-6.
16. Mockridge CI, Chapman CJ, Spellerberg MB, Sheth B, Fleming TP, Isenberg DA, et al. Sequence analysis of V(4-34)-encoded antibodies from single B cells of two patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1998;114:129-36.
17. Cappione A, III, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, Silverman G, et al. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 2005; 115:3205-16.
18. William J, Euler C, Christensen S, Shlomchik MJ. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 2002;297:2066-70.
19. Schroder AE, Greiner A, Seyfert C, Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci USA 1996;93:221-5.
20. Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 2005;23:6333-8.